• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

儿童先心病介入治疗中导管室的风险管理措施

通讯作者: 陈延茹, cyr228@163.com
DOI:10.12201/bmr.202503.00062
声明:预印本系统所发表的论文仅用于最新科研成果的交流与共享,未经同行评议,因此不建议直接应用于指导临床实践。

Risk management of catheterization room in interventional therapy of congenital heart disease in children

Corresponding author: chen yanru, cyr228@163.com
  • 摘要:目的 研究导管室风险管理在儿童先天性心脏病(CHD)介入治疗中的应用,以期构建一套全面、实用的风险管理干预方案,提升治疗安全性与患者体验。方法 选取了2021年1月至2022年12月期间在我中心医院接受介入治疗的120例先天性心脏病患儿,随机分为两组,每组60例。观察组实施了详细的风险管理干预方案,包括术前风险评估、心理干预、术中监测与预防、压力管理以及术后护理风险管理;对照组则接受常规护理。通过自制满意度问卷评估服务,对并发症进行界定和统计,以及监测患儿的心理健康状态,比较两组的并发症发生率、心理健康状态和满意度。结果 观察组在风险管理策略下,患儿的焦虑和抑郁水平显著下降,焦虑平均分从治疗前的56.8±4.6分降至30.8±2.6分,抑郁平均分从55.8±2.5分降至31.4±1.6分,改善效果显著(P<0.001)。风险管理策略实施后,观察组的风险事件发生率明显低于对照组(5% vs 15%),护患纠纷情况也显著减少。观察组的总满意度为95.0%,显著高于对照组的78.3%(P=0.0014)。结论 全面的风险管理方案在儿童先天性心脏病介入治疗中能有效降低风险事件和护患纠纷,显著提升患儿的满意度和心理健康状态,证明了风险管理策略在优化治疗过程、减少不良事件、增进医患和谐方面的重要作用。然而,研究存在样本量较小的局限性,未来研究需扩大样本规模,以验证策略的广泛适用性和长期效果。

    关键词: 风险管理;先心病介入治疗

     

    Abstract: Abstract:Objective To study the application of catheterization laboratory risk management in the interventional treatment of congenital heart disease (CHD) in children, with the aim of developing a comprehensive and practical risk management intervention plan to enhance treatment safety and patient experience. Methods A total of 120 pediatric patients with CHD who underwent interventional treatment at our center hospital from January 2021 to December 2022 were selected and randomly divided into two groups, each consisting of 60 patients. The observation group was subjected to an elaborate risk management intervention plan, including preoperative risk assessment, psychological intervention, intraoperative monitoring and prevention, stress management, as well as postoperative nursing risk management; the control group received routine care. Complications were defined and statistically analyzed, and the mental health status of the children was monitored. The incidence of complications, mental health status, and satisfaction were compared between the two groups using a self-designed satisfaction questionnaire. Results Under the risk management strategy, the levels of anxiety and depression in the observation group significantly decreased, with the average anxiety score dropping from 56.8 ± 4.6 before treatment to 30.8 ± 2.6 after treatment, and the average depression score falling from 55.8 ± 2.5 to 31.4 ± 1.6, demonstrating a significant improvement (P < 0.001). After implementing the risk management strategy, the incidence of risk events in the observation group was notably lower than that in the control group (5% vs 15%), and medical disputes were also significantly reduced. The overall satisfaction rate for the observation group was 95.0%, significantly higher than the control groups 78.3% (P = 0.0014). Conclusion A comprehensive risk management plan can effectively reduce risk events and medical disputes in the interventional treatment of pediatric CHD, significantly improving patient satisfaction and mental health status. This confirms the vital role of risk management strategies in optimizing the treatment process, reducing adverse events, and enhancing doctor-patient harmony. However, the study has limitations due to its small sample size; future research should expand the sample scale to verify the wide applicability and long-term effects of the strategy.

    Key words: Risk Management; Interventional Treatment for Congenital Heart Disease

    提交时间:2025-03-21

    版权声明:作者本人独立拥有该论文的版权,预印本系统仅拥有论文的永久保存权利。任何人未经允许不得重复使用。
  • 图表

  • 丁喜凤, 刘赵朋, 钟颖琦, 郑景辉. 中医药治疗冠心病PCI术后焦虑抑郁的研究进展. 2025. doi: 10.12201/bmr.202503.00078

    王可欣, 张少强. 不同功效组合的中药复方联合常规西药治疗冠心病合并抑郁的网状Meta 分析. 2024. doi: 10.12201/bmr.202410.00055

    张一颖, 杜昱, 李萌, 李园白, 杨硕, 刘方舟, 王静, 李逸豪, 杨阳. 基于医案大数据分析系统探索冠心病古方用药特点. 2021. doi: 10.12201/bmr.202110.00027

    孙保峰, 张伟祎, 杨扬, 李郁鸿. 基于态势感知平台的大型医院网络安全风险管理实践. 2024. doi: 10.12201/bmr.202408.00065

    周妮, 谷强. 儿童大叶性肺炎病程的危险因素及风险预测. 2025. doi: 10.12201/bmr.202504.00059

    孙婕. 单病种管理系统的设计与应用. 2023. doi: 10.12201/bmr.202303.00020

    熊双琳, 徐萍. 从心脾论治儿童期特应性皮炎经验探析. 2024. doi: 10.12201/bmr.202412.00043

    黄天凤. 老年慢病共病模式及管理策略研究现状. 2025. doi: 10.12201/bmr.202501.00080

    陈芸琪, 栾志勇. 干细胞治疗先天性巨结肠的研究进展. 2024. doi: 10.12201/bmr.202410.00021

    向聪, 高小莲, 熊钱芬, 王鹤情, 罗燕玲, 祝鑫红, 陶军秀. 基于内容分析法的慢性病健康管理信息化特征研究. 2024. doi: 10.12201/bmr.202408.00058

  • 序号 提交日期 编号 操作
    1 2024-11-09

    bmr.202503.00062V1

    下载
  • 公开评论  匿名评论  仅发给作者

引用格式

戴丽君, 杨伟力, 陈延茹. 儿童先心病介入治疗中导管室的风险管理措施. 2025. biomedRxiv.202503.00062

访问统计

  • 阅读量:156
  • 下载量:1
  • 评论数:0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误